🇺🇸 FDA
Pipeline program

1-(3-(fluoro-18F)benzyl)guanidine ([18F]mFBG)

21-513

Phase 2 small_molecule active

Quick answer

1-(3-(fluoro-18F)benzyl)guanidine ([18F]mFBG) for Pheochromocytoma – endocrine adrenal tumor is a Phase 2 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Disc Medicine
Indication
Pheochromocytoma – endocrine adrenal tumor
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials